suramin has been researched along with transforming growth factor beta in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (77.27) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bascom, CC; Beauchamp, RD; Lyons, RM; Miller, DA; Moses, HL; Sheng, HM; Torre-Amione, G | 1 |
| Gomella, LG; Kasid, A; LaRocca, RV; Linehan, WM; Myers, CE; Sargent, ER; Stein, CA; Wade, TP | 1 |
| Bolander, ME; Jingushi, S; Joyce, ME; Scully, SP | 1 |
| Cook, PW; Pittelkow, MR; Shipley, GD | 1 |
| DeGeorges, A; Desgrandchamps, F; Tatoud, R; Thomas, F | 1 |
| Clemmons, DR; McCusker, RH | 1 |
| Leung, GK; Peehl, DM; Wong, ST | 1 |
| Becquet, F; Courtois, Y; Goureau, O; Lepoivre, M | 1 |
| Gebhardt, MC; Jennings, CL; Kloen, P; Mankin, HJ; Springfield, DS | 1 |
| Kraft, A; Reid, LM; Zvibel, I | 1 |
| Eddy, HA; Jacobs, SC; Kyprianou, N; Sklar, GN | 1 |
| Disser, M; Haberstroh, U; Stahl, RA; Thaiss, F; Wolf, G; Zahner, G | 1 |
| Myers, CE; Samid, D; Shack, S | 1 |
| Goncharova, EI; Nádas, A; Rossman, TG | 1 |
| Weyman, CM; Wolfman, A | 1 |
| Boylan, M; Lynch, M; van den Berg, HW | 1 |
| Lee, JC; Yeh, LC | 1 |
| Breuer, R; Goldstein, RH; Izbicki, G; Lossos, IS; Or, R | 1 |
| Cerra, A; Chamberlain, CG; Mansfield, KJ | 1 |
| Chan, YS; Foster, W; Fu, FH; Huard, J; Li, Y | 1 |
| Areas, MA; De Oliveira Moreira, D; Marques, MJ; Matsumura, CY; Neto, HS; Pereira, JA; Ramos, LA; Taniguti, AP | 1 |
| Akova, YA; Bakar, C; Oktem, C; Oto, S; Ozdemir, H; Toru, S | 1 |
1 review(s) available for suramin and transforming growth factor beta
| Article | Year |
|---|---|
[Peptide growth factors in the prostate].
Topics: Adenocarcinoma; Epidermal Growth Factor; Fibroblast Growth Factors; Humans; Interleukin-6; Male; Nerve Growth Factors; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Suramin; Transforming Growth Factor alpha; Transforming Growth Factor beta | 1993 |
21 other study(ies) available for suramin and transforming growth factor beta
| Article | Year |
|---|---|
Phenotypic alterations in fibroblasts and fibrosarcoma cells that overexpress latent transforming growth factor-beta 1.
Topics: Animals; Blotting, Northern; Cell Line; Embryo, Mammalian; Fibroblasts; Fibrosarcoma; Gene Expression; Kinetics; Mice; Mice, Inbred C3H; Phenotype; Plasmids; Poly A; Receptors, Cell Surface; Receptors, Transforming Growth Factor beta; RNA; RNA, Messenger; Sarcoma, Experimental; Suramin; Transfection; Transforming Growth Factor beta | 1992 |
Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture.
Topics: Carcinoma, Renal Cell; Cell Division; Dose-Response Relationship, Drug; Humans; Kidney Neoplasms; Suramin; Transforming Growth Factor beta; Tumor Cells, Cultured | 1992 |
Role of growth factors in fracture healing.
Topics: Animals; Bony Callus; Cell Division; Extracellular Matrix Proteins; Femoral Fractures; Fibroblast Growth Factors; Gene Expression; Growth Substances; Male; Organ Culture Techniques; Platelet-Derived Growth Factor; Rats; Rats, Inbred Strains; Suramin; Transforming Growth Factor beta; Wound Healing | 1991 |
Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors.
Topics: Animals; Cell Division; DNA Replication; Epidermal Growth Factor; ErbB Receptors; Fibroblasts; Growth Substances; Heparitin Sulfate; Humans; In Vitro Techniques; Keratinocytes; Mice; Skin; Suramin; Transforming Growth Factor beta | 1991 |
Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro.
Topics: Alkaloids; Animals; Blotting, Western; Carrier Proteins; Cell Line; Culture Media, Conditioned; Cytokines; Epidermal Growth Factor; Fibroblast Growth Factor 2; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Mice; Muscle, Smooth, Vascular; Muscles; Rats; Staurosporine; Suramin; Swine; Thrombin; Transforming Growth Factor beta | 1994 |
Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors.
Topics: Cell Division; Cells, Cultured; Epithelial Cells; Epithelium; Glucose; Growth Substances; Humans; Interferon-gamma; Keratins; Male; Phenotype; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Reference Values; Suramin; Transforming Growth Factor beta; Tretinoin | 1994 |
Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation.
Topics: Amino Acid Oxidoreductases; Animals; Catechols; Cattle; Cells, Cultured; Enzyme Induction; Epidermal Growth Factor; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Heparin; Humans; Interferon-gamma; Kinetics; Lipopolysaccharides; Molsidomine; Nitric Oxide Synthase; Nitriles; Nitrites; Pigment Epithelium of Eye; Recombinant Proteins; Suramin; Transforming Growth Factor beta; Tyrphostins; Vasodilator Agents | 1993 |
Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines.
Topics: Bone Neoplasms; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Osteosarcoma; Receptors, Transforming Growth Factor beta; Suramin; Transforming Growth Factor beta; Tumor Cells, Cultured | 1994 |
Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
Topics: Animals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Division; Gene Expression; Glycosaminoglycans; Growth Substances; Humans; Insulin-Like Growth Factor II; Liver; Liver Neoplasms; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sensitivity and Specificity; Suramin; Transforming Growth Factor beta; Tumor Cells, Cultured | 1993 |
Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.
Topics: Apoptosis; Clusterin; Combined Modality Therapy; DNA, Neoplasm; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Glycoproteins; Humans; Male; Molecular Chaperones; Neoplasm Proteins; Prostatic Neoplasms; RNA, Messenger; Suramin; Transforming Growth Factor beta; Tumor Cells, Cultured | 1993 |
TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression.
Topics: Animals; Cell Division; Glomerular Mesangium; Immunoglobulin G; Platelet-Derived Growth Factor; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-sis; Rats; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Suramin; Transforming Growth Factor beta | 1993 |
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.
Topics: Animals; Cell Division; Cell Survival; DNA Replication; Female; Glutamine; HLA-A3 Antigen; Humans; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Phenotype; Phenylacetates; Prostatic Neoplasms; RNA, Neoplasm; Suramin; Transforming Growth Factor beta; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Serum deprivation, but not inhibition of growth per se, induces a hypermutable state in Chinese hamster G12 cells.
Topics: Animals; Antioxidants; Ascorbic Acid; Cell Division; Cell Line; Cricetinae; Cricetulus; Culture Media, Serum-Free; Dichlororibofuranosylbenzimidazole; Escherichia coli; Mannitol; Mathematics; Models, Genetic; Mutagenesis; Recombinant Proteins; S Phase; Suramin; Transfection; Transforming Growth Factor beta | 1996 |
Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation.
Topics: Animals; Cell Differentiation; Culture Media, Conditioned; Fibroblast Growth Factor 2; Genes, ras; Humans; Insulin-Like Growth Factor I; Mice; Mice, Inbred C3H; Muscle, Skeletal; Suramin; Transforming Growth Factor beta | 1997 |
The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of ta
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Suramin; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured | 1998 |
Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcification, Physiologic; Cell Differentiation; Cells, Cultured; Endothelial Growth Factors; Gene Expression; Kinetics; Lymphokines; Oligonucleotides, Antisense; Rats; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suramin; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
The effect of suramin on bleomycin-induced lung injury.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Line; Collagen; Fibroblasts; Humans; Injections, Intraperitoneal; Instillation, Drug; Luciferases; Lung; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Promoter Regions, Genetic; Pulmonary Fibrosis; Suramin; Transfection; Transforming Growth Factor beta | 2000 |
Exacerbation of TGF-beta-induced cataract by FGF-2 in cultured rat lenses.
Topics: Actins; Animals; Animals, Newborn; Cataract; Collagen Type I; DNA; Drug Combinations; Drug Synergism; Female; Fibroblast Growth Factor 2; Fibronectins; Fluorescent Antibody Technique, Indirect; Lens, Crystalline; Organ Culture Techniques; Platelet-Derived Growth Factor; Polymers; Rats; Rats, Wistar; Sulfonic Acids; Suramin; Transforming Growth Factor beta; Transforming Growth Factor beta2 | 2003 |
The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury.
Topics: Animals; Antineoplastic Agents; Cicatrix; Fibroblasts; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Sprains and Strains; Suramin; Transforming Growth Factor beta; Wound Healing | 2005 |
Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy.
Topics: Age Factors; Analysis of Variance; Animals; Antineoplastic Agents; Cardiomyopathies; Creatine Kinase; Disease Models, Animal; Dystrophin; Electrocardiography; Electroencephalography; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscular Dystrophy, Duchenne; Suramin; Transforming Growth Factor beta | 2013 |
Suramin, Genistein and Collagen Matrix (DuraGen) for Delayed Adjustment after Strabismus Surgery: Which One is Best?
Topics: Animals; Antineoplastic Agents; Biomarkers; Collagen; Conjunctiva; Endoglin; Epithelium; Female; Fibrosis; Genistein; Inflammation; Male; Oculomotor Muscles; Ophthalmologic Surgical Procedures; Rabbits; Strabismus; Suramin; Suture Techniques; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2016 |